Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

General Gastroenterology Dermatologic Outcomes of GLP-1 RA Use General Gastroenterology The Gut-Joint Axis: What Research Actually Says About Diet and Spondyloarthritis The 25th Anniversary of Imatinib and the Evolution of Small Molecule Inhibitors GLP-1 Receptor Agonist Therapy: Management…

News

News Endocrinology Advisor 7 days ago
High TyG-BMI Associated With Poorer Outcomes After Septal Myectomy in Cardiomyopathy
Elevated triglyceride glucose-body mass index was associated with worse clinical outcomes in patients with hypertrophic obstructive cardiomyopathy treated with septal myectomy.
Read more
Report
News Endocrinology Advisor 7 days ago
Medical Societies Urge Congress to Close the Women's Health Gap
Medical societies are urging Congress to make a strategic financial commitment to close the women's health gap and improve evidence-based care.
Read more
Report
News Infectious Disease Advisor 7 days ago
Evaluating Predictors of HBsAg Seroclearance in HIV/HBV-Coinfected Adults
Universal neonatal HBV vaccination and low baseline levels are linked to HBsAg seroclearance in HIV/HBV coinfection.
Read more
Report
News Clinical Advisor 7 days ago
GLP-1 Receptor Agonist Therapy: Management, Maintenance, and Long-Term Outcomes
Melissa Glassford, DNP, discusses strategies for managing GLP-1 therapy gaps, dose titration, weight plateaus, and side effects in obesity.
Read more
Report
News Cancer Therapy Advisor 7 days ago
The 25th Anniversary of Imatinib and the Evolution of Small Molecule Inhibitors
In 2001, imatinib was the first proof that small molecule inhibitors targeting molecular drivers of cancer could be an effective treatment.
Read more
Report
Pro access
Upgrade to see all 19 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.